|
IPO Status: Closed [16th Jul 2021 to 20th Jul 2021]
Tatva Chintan Pharma, a chemical manufacturing company in India is coming up with an IPO of Rs. 500 Cr. The IPO opens for subscription on 16 July and closes on 20 July. The price band is fixed at Rs. 1073-1083, the floor price is 107.3 times and the cap price is 108.3 times of Rs. 10 face value. One can apply for the lot size of 13 shares and it's multiple. Stay updated to know more about Tatva Chintan Pharma IPO including business overview, financial performance, recommendations, live subscription, allotment, GMP, and more.
IPO Issue Opening Date: | 16th Jul 2021 |
IPO Issue Closing Date: | 20th Jul 2021 |
IPO Issue Price: | ₹1073-1083 Per Share |
DRHP: | View DRHP |
RHP: | View RHP |
IPO Listing At: | BSE, NSE |
Retail Quota: | 50% |
IPO Issue Type: | Book Build Issue |
IPO Issue Size: | ₹500 Cr |
Offer for Sale: | ₹275 Cr |
Fresh Issue: | ₹225 Cr |
Face Value: | ₹10 Per Equity Share |
IPO Discount: | NA |
Promoter Holding Pre IPO: | 100% |
Promoter Holding Post IPO: | 79.17% |
Allotment Status: | Allotment Status |
BSE Code: | 543321 |
NSE Code: | TATVA |
In this section we have covered all important dates related to Tatva Chintan Pharma IPO. Dates are updated as they are announced. The most noted dates are IPO start date and IPO end date, which one should use to participate in IPO.
IPO Activity | Date |
---|---|
IPO Issue Open | 16th Jul 2021 |
IPO Issue Close | 20th Jul 2021 |
Basis of Allotment Date* | 26th Jul 2021 |
Refunds Initiation* | 27th Jul 2021 |
Credit of Shares to Demat* | 28th Jul 2021 |
IPO Listing Date* | 29th Jul 2021 |
* - Tentative Dates
IPO Activity | Date |
---|---|
Issue Price | ₹1073-1083 |
Market Lot: | 13 Shares |
1 Lot Amount: | ₹14079 |
Max Retail Lots: | 182 shares(14 lots) |
Min HNI Lots: | 195 shares(15 lots) |
Save 60% to 90% Brokerage
Start your investment journey with India's number one discount broker - Zerodha. Free delivery trade and free mutual funds Investment. Flat Rs 20 for Intraday,F&O, Currency and Commodity Trade.
Open Account Now
|
Tatva Chintan Pharma Chem Limited is one of the leading Indian manufacturers of Structure Directing Agents (SDAs) for zeolites. The company manufactures structure-directing agents, phase transfer catalysts, pharmaceutical, and agrochemical ingredients, and other specialty chemicals to meet diverse requirements of various industries i.e. automotive, agrochemicals, petroleum, paints and coatings, dyes and pigments, pharmaceutical, personal care, and others. Merck, Bayer AG, SRF Ltd, Navin Fluorine International Ltd, Atul Ltd, Divi's Laboratories, etc. are some of its prominent customers. The company sells its products in India and overseas markets such as the USA, UK, China, Germany, and South Africa.
Incorporation | Sector | IPO Issue Size | Website |
1996 | Specialty Chemical | ₹500 Cr | http://www.tatvachintan.com/ |
The table below is live update of IPO bidding details from NSE and BSE.
Day | QIB | NII | RII | Total | |
---|---|---|---|---|---|
# of Shares Offered | 931,966 (28.57%) | 698,975 (21.43%) | 1,630,941 (50%) | 3,261,882 | 1 | 16th Jul 2021 17:03 | 0.50x | 1.14x | 8.24x | 4.51x | 2 | 19th Jul 2021 17:02 | 1.97x | 12.21x | 23.74x | 15.05x | 3 | 20th Jul 2021 17:03 | 185.23x | 512.22x | 35.35x | 180.36x |
Past performance and financial results of Tatva Chintan Pharma.
Tatva Chintan Pharma Chem Financials | 31-Mar-2021 | 31-Mar-2020 | 31-Mar-2019 | 31-Mar-2018 |
---|---|---|---|---|
Total Assets | ₹314.80 Cr | ₹248.94 Cr | ₹187.51 Cr | ₹143.72 Cr |
Total Income | ₹306.29 Cr | ₹264.62 Cr | ₹206.80 Cr | ₹137.29 Cr |
Net Profit/Loss | ₹52.26 Cr | ₹37.79 Cr | ₹20.54 Cr | ₹12.29 Cr |
Last Updated on 2021-09-27T10:40:21+00:00
Free Delivery for Lifetime
Flat ₹15 Per Trade in F&O
Rs 0 Demat AMC
FREE Account Opening (₹650)
Trade at Flat ₹20 per Trade
Pay-as-you-go Demat AMC
Flat ₹20 Per Trade
Free Trading Tips & Software